Literature DB >> 30572440

Transurethral procedures in the treatment of benign prostatic hyperplasia: A systematic review and meta-analysis of effectiveness and complications.

Feng Sun, Xincheng Sun, Qinglu Shi, Yuzhang Zhai.   

Abstract

BACKGROUND: With the progress of surgical techniques and instruments, various minimally invasive surgical therapies were developed to treat benign prostatic hyperplasisa (BPH). However, the efficacy and safety of different transurethral procedures for the treatment of BPH are still undefined.
METHOD: A systematic search was performed for all randomized controlled trials (RCTs), which compared the transurethral procedures for BPH from 1995 to 2016. The clinical baseline characteristics, International Prostate Symptom Score (IPSS), quality of life (QoL), postvoid residual (PVR), maximum flow rate (Qmax), short-term and long-term complications were analyzed using RevMan and ADDIS software. RESULT: Eighty-eight randomly controlled trials and fifteen procedures were included in the network meta-analysis. HoLEP greatly inproved PVR. TmLRP had the best efficacy in improving QoL score. Diode laser vaporization of prostate was superior in improving IPSS and Qmax. Diode laser through vaporization required the shortest time in catheterization, while Nd:YAG was the longest procedure. For the hospitalization time, TUR was the longest and HoLEP was the shortest. TmLRP was related to the lowest postoperative hemoglobin decrease. TmLEP had the least rates of occurrence of hematuria, reoperation and erectile dysfunction. HoLEP was the best choice to reduce the incidence of recatheterization, urinary retention, urinary tract infection, stress urinary incontinence and retrograde ejaculation. The complications such as blood transfusion, urethral stricture, bladder neck contracture were relatively rare in the patients who underwent diode laser vaporization of prostate.
CONCLUSION: Compared with other transurethral procedures, thulium, holmium and diode lasers were associated with better efficacy and fewer complications.

Entities:  

Mesh:

Year:  2018        PMID: 30572440      PMCID: PMC6320039          DOI: 10.1097/MD.0000000000013360

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


Introduction

Benign prostate hyperplasia is a common disease among elderly men, which is the major cause of lower urinary tract symptoms (LUTS).[ According to the statistics, 60% of men older than 60 years suffer from BPH and LUTS, which greatly decrease the quality of life.[ Surgical treatment is often the most effective intervention.[ For surgical procedures, monopolar TURP (M-TURP) was considered as “gold standard” for the treatment of BPH in the past decades, although it is associated with complications such as transurethral resection syndrome (TURS) and blood loss.[ With the progress of surgical techniques and development of instruments, multitudinous transurethral procedures have been invented to overcome the faultiness of M-TURP. These alternative transurethral procedures include bipolar plasmakinetic, electrovaporization, and various lasers.[ The modalities of prostate tissue ablation include enucleation, resection, and vaporization.[ All these available surgical treatments are widely used, and each surgical procedure has its own advantage or disadvantage. However, the efficacy and safety of different transurethral procedures for the treatment of BPH are still undefined. Hundreds of randomized controlled trials compared these different types of transurethral procedures. However, most of them only compared 2 or 3 types of procedures. The efficacy and safety of different surgical procedures are difficult to estimate. In this study, we made a network meta-analysis to compare the efficacy and safety of different transurethral procedures for BPH.

Methods

Literature search strategy

A systematic search was performed for all randomized controlled trials (RCTs), which compared the transurethral procedures for BPH from 1995 to 2016. The literatures were based on the following databases: Embase, PubMed/Medline, Cochrane Library, and Scopus. The keywords included: randomized, benign prostatic hyperplasia, BPH, Thulium laser, Holmium laser, photoselective vaporization of prostate, Diode laser, Nd:YAG laser, “KTP: YAG laser, interstitial laser, monopolar transurethral resection, bipolar transurethral resection, plasmakinetic, and electrovaporization. There was no restriction on the language of the articles.

Inclusion and exclusion criteria

Inclusion criteria included: RCTs; patients diagnosed with BPH and needed surgical therapy; trials comparing different transurethral procedures for the treatment of BPH; at least one of the primary outcomes was clearly defined. Exclusion criteria included: patients with previous prostatic surgery, neurogenic bladder and urethral strictures; patients with prostatic carcinoma; open surgery, laparoscopic operation, transurethral microwave therapy, prostate stent and water induced thermotherapy; published only in abstracts; enrolled patients <40 in one trial; (6) animal experiment. This study was approved by The Ethics Committee of Cangzhou People Hospital. Participants have provided their written informed consent to participate in this study.

Data extraction

We collected the following data from these literatures: the quality of trials; clinical basic characteristics; effectiveness index, including IPSS, Qmax, PVR, and QoL scores; operating time, hospitalization and catheterization time; short-term complications-related outcomes, and long-term complications.

Quality analysis

The data abstraction and quality evaluation were performed independently by 2 reviewers (FS and JL) according to Cochrane guidelines 5.1.0 and quality-control standards set by Jada.[ A third member (YZ) participated in the discussion when divergence appeared. The Cochrane Handbook evaluation elements include randomization, allocation concealment, blinding, incomplete outcome data, and selective reporting.[ But blinding is impractical in clinical work. So “blinding” was cancelled in this study. The judgments were categorized as “low risk of bias,” “high risk of bias” or “unclear risk of bias.” The risk of bias of all included studies was analyzed by RevMan 5.3.0 software. In addition, there were many trials related to bipolar TURP. In fact, it represents different techniques. International Electrotechnical Commission (http://www.iec.ch), designed the bipolar as mirrored dual-loop distal consisting of active and passive electrode and both electrodes must be attached in a single-port system. The plasmakinetic system reaches the specification for bipolar TURP. Though bipolar transurethral resection in saline (TURis) is another main transurethral procedure for BPH, it does not conform to the definition of International Electrotechnical Commission. So articles related to plasmakinetic system or TURis were distinguished in our research.

Statistical analysis

We relied on PRISMA criteria and PICO methodology was used to analyze the outcomes of interest and population.[ ADDIS 1.16.6 software was used to conduct this network meta-analysis. ADDIS is a nonprogramming software adhered to Bayesian approach, which helps us to predict the comparable estimates between indirect comparisons. By means of this software, the relative effect estimates were calculated and the procedures could be sorted from the best to the worst. We created a consistency model to combine the effect of indirect comparisons and P < . 05 was set as significant inconsistency. The results are expressed as rank probability.

Results

Characteristics of eligible studies

Around 1850 records were found through initial searching. Due to duplicate or nonrandomized, 1620 articles were excluded. About 88 randomly controlled trials (RCTs) in 97 articles[ (11187 enrolled patients) were finally included in the network meta-analysis. Figure 1 showed the flow diagram of the search. Table 1  showed the basic characteristics of included RCTs, such as types of prostate tissue ablation, the number of patients, age, prostate size, Qmax, PVR, IPSS, QoL, and the max follow-up time. The basic characteristics of enrolled patients were substantially equal in general. Fifteen procedures were studied in this systematic review and the numbers beside the lines were the quantities of comparative trials (Fig. 2). The risk of bias was shown in Figure 3. “Blinding” was ignored in this study because it is impractical in clinical work. Overall, the quality of these studies was relatively high through the other 5 items introduced by Cochrane criterion.
Figure 1

Flowchart for this network meta-analysis.

Table 1

The basic characteristics of included randomly controlled trials.

Figure 2

Comparison network of included trials. DiLEP = diode laser enucleation of prostate, HoLEP = holmium laser enucleation of prostate, HoLRP = holmium laser resection of prostate, ILC = Intrestitial laser coagulation, M-TURP = monopolar transurethral resection of prostate, PKEP = plasmakinetic enucleation of prostate, PKRP = plasmakinetic resection of prostate, PVP = photoselective vaporization of prostate, TmLRP = thulium laser resection of prostate, TmLEP = thulium laser enucleation of prostate, TURis = bipolar transurethral resection in saline, TUVP =  transurethral electrovaporization of prostate.

Figure 3

Risk of bias for selected trials.

Flowchart for this network meta-analysis. The basic characteristics of included randomly controlled trials. The basic characteristics of included randomly controlled trials. Comparison network of included trials. DiLEP = diode laser enucleation of prostate, HoLEP = holmium laser enucleation of prostate, HoLRP = holmium laser resection of prostate, ILC = Intrestitial laser coagulation, M-TURP = monopolar transurethral resection of prostate, PKEP = plasmakinetic enucleation of prostate, PKRP = plasmakinetic resection of prostate, PVP = photoselective vaporization of prostate, TmLRP = thulium laser resection of prostate, TmLEP = thulium laser enucleation of prostate, TURis = bipolar transurethral resection in saline, TUVP =  transurethral electrovaporization of prostate. Risk of bias for selected trials. Among reported trials, standard TURP (M-TURP) was the most commonly used technology, which was shown in 69 studies. The frequency of surgical energy platform from high to low was: M-TURP (69) > bipolar plasmakinetic (36) > electrovaporization (16) > thulium laser (15) = holmium laser (15) > greenlight laser (14) > TURis (12) > Nd:YAG (8) > diode laser (3) > KTP/Nd:YAG (2) > Intrestitial laser (1). The main modalities of tissue ablation include enucleation, resection, and vaporization.

Effectiveness index evaluation after operation

Effectiveness index included IPSS, Qmax, PVR, and QoL scores; operating time, hospitalization, and catheterization time. For IPSS diode laser vaporization of prostate was significantly superior to other procedures, and TUVP was the worst one. The relative effect estimate of diode laser vaporization versus TUVP was −4.02 (−8.05, −0.06). Rank probability of IPSS from the best to the worst was diode laser vaporization > Nd:YAG > PVP > KTP/Nd:YAG > ILC > TURis > TmLRP > TmLEP > HoLEP > M-TURP > HoLRP > DiLEP > transurethral plasmakinetic resection of prostate (PKRP) > PKEP > TUVP. (Figure 4A) Diode laser vaporization of prostate also had the best efficiency in improving Qmax,. Rank probability of Qmax from the best to the worst was diode laser vaporization > PVP > Nd:YAG > KTP/Nd:YAG > ILC > HoLRP > TmLRP > TURis > TmLEP > M-TURP > PKRP > HoLEP > DiLEP > PKEP > TUVP (Fig. 4B). The relative effect estimate of the best one versus the worst (TUVP) was −5.40 (−10.14, −0.67). Pooled data revealed that HoLEP was the best choice for improving PVR, and KTP/Nd:YAG was the worst one. The relative effect estimate was 28.26 (−21.05, 77.36). Rank probability of Qmax from the best to the worst was HoLEP > Nd:YAG > PVP > ILC > diode laser vaporization > PKRP > TURis > M-TURP > HoLRP > TmLRP > TmLEP > DiLEP > PKEP > TUVP > KTP/Nd:YAG (Fig. 4C). For QoL, TmLRP was the best technique and TUR was the worst one. The relative effect estimate was 0.18 (−0.29, 0.64). Rank probability from the best to the worst: TmLRP > TmLEP > HoLEP > HoLRP > PVP > DiLEP > M-TURP > PKRP > PKEP > TUVP > TURis (Fig. 4D).
Figure 4

Rank probability of functional outcomes. (A) Rank probability of IPSS; (B) rank probability of Qmax; (C) rank probability of PVR; (D) rank probability of QoL. IPSS = International Prostate Symptom Score.

Rank probability of functional outcomes. (A) Rank probability of IPSS; (B) rank probability of Qmax; (C) rank probability of PVR; (D) rank probability of QoL. IPSS = International Prostate Symptom Score. Perioperative outcomes included operation time, catheterization, and hospitalization time. PKRP needed the fewest time in operation compared with other transurethral procedures and HoLRP was the slowest one. The relative effect estimate of PKRP versus HoLRP was 21.63 (6.65, 36.36). Rank probability from the fastest to the slowest: PKRP > DiLEP > M-TURP > Nd:YAG > KTP/Nd:YAG > TUVP > TURis > TmLRP > diode laser vaporization > PVP > PKEP > HoLEP > TmLEP > HoLRP (Fig. 5A). Diode laser through vaporization required the shortest time in catheterization, while Nd:YAG was the longest one. The relative effect estimate of Diode laser versus Nd:YAG laser was −11.82 (−16.59, −7.10). Rank probability from the shortest to the longest: diode laser vaporization > HoLRP > TmLRP > PVP > DiLEP > TmLEP > HoLEP > PKRP > PKEP > TURis > TUVP > M-TURP > ILC > Nd:YAG (Fig. 5B). For hospitalization time, TUR is required the longest and HoLEP was the shortest. The relative effect estimate of HoLEP versus TUR was −4.98 (−14.57, 4.68). Rank probability from the shortest to the longest: HoLEP > PVP > TmLRP > TmLEP > HoLRP > DiLEP > diode laser vaporization > Nd:YAG > PKRP > M-TURP > PKEP > TUVP > TURis (Fig. 5C).
Figure 5

Rank probability of perioperation-related outcomes. (A) Rank probability of operation time; (B) rank probability of catheterization time; (C) rank probability of hospitalization time.

Rank probability of perioperation-related outcomes. (A) Rank probability of operation time; (B) rank probability of catheterization time; (C) rank probability of hospitalization time.

Complication evaluation after operation

Short-term complications included TURS, hematuria, postoperative hemoglobin decrease, blood transfusion, clot retention, recatheterization, urinary retention, dysuria, and urinary tract infection. Fifty articles reported TURS and the network analysis showed that M-TURP was related to the highest incidence rate of TURS and PKRP was related to the lowest occurrence rate. The relative effect estimate of PKRP versus M-TURP was 16.24 (4.02, 22.53) (Fig. 6A). Hematuria was rarely observed in TmLEP and mostly happened in M-TURP. TmLRP led the lowest postoperative hemoglobin decrease and TUR was the worst one. M-TURP was the most common technique associated with blood transfusion and Diode laser vaporization was the safest choice; Clot retention was mostly observed in M-TURP but rarely in PVP (Fig. 6B–E).
Figure 6

Rank probability of short-term complications. (A) Rank probability of TURS; (B) rank probability of hematuria; (C) rank probability of postoperative hemoglobin decrease; (D) rank probability of blood transfusion; (E) rank probability of clot retention; (F) rank probability of recatheterization; (G) rank probability of urinary retention; (H) rank probability of dysuria; (I) rank probability of urinary tract infection. TURS = transurethral resection syndrome.

Rank probability of short-term complications. (A) Rank probability of TURS; (B) rank probability of hematuria; (C) rank probability of postoperative hemoglobin decrease; (D) rank probability of blood transfusion; (E) rank probability of clot retention; (F) rank probability of recatheterization; (G) rank probability of urinary retention; (H) rank probability of dysuria; (I) rank probability of urinary tract infection. TURS = transurethral resection syndrome. Recatheterization occurred rarely in HoLEP and commonly in KTP/Nd:YAG. Urinary retention always happened to the patients, who underwent Nd:YAG laser resection and it was barely occurred in HoLEP. TUVP had the highest rate of dysuria and PKEP was the best one; In addition, urinary tract infection was rare in patients treated with HoLEP (Fig. 6F–I). Long-term complications included urethral stricture, bladder neck contracture, stress urinary incontinence, reoperation, retrograde ejaculation, and erectile dysfunction. There were 69 articles reported urethral stricture. Diode laser vaporization showed the best security due to the network analysis and TUR was the most dangerous one. The relative effect estimate of diode laser vaporization versus TUR was 0.77 (0.32, 1.72) (Fig. 7A). Around 46 studies were related to bladder neck contracture. Diode laser vaporization leaded to the lowest occurrence rate and KTP/Nd:YAG laser leaded to the highest incidence rate (Fig. 7B). Stress urinary incontinence was frequently occurred in KTP/Nd:YAG laser and HoLEP was on the contrary (Fig. 7C).
Figure 7

Rank probability of long-term complications. (A) Rank probability of urethral stricture; (B) rank probability of bladder neck contracture; (C) rank probability of stress urinary incontinence; (D) rank probability of reoperation; (E) rank probability of erectile dysfunction; (F) rank probability of retrograde ejaculation.

Rank probability of long-term complications. (A) Rank probability of urethral stricture; (B) rank probability of bladder neck contracture; (C) rank probability of stress urinary incontinence; (D) rank probability of reoperation; (E) rank probability of erectile dysfunction; (F) rank probability of retrograde ejaculation. Reoperation was reported in 37 studies. The reasons included bleeding, clot retention, urethral stricture, bladder neck contracture recurrence of hyperplasia, and so on. The particular reasons were too disperse to make subgroup analysis. We analyzed the overall reoperation rate. ILC was the most common technique inducing reoperation, while TmLEP was the safest choice (Fig. 7D). For the male sexual function, our attention was fixed on the occurrence of retrograde ejaculation and erectile dysfunction. TmLEP had the least rates of occurrence of erectile dysfunction, while KTP/Nd:YAG laser leaded to the highest incidence rate. Retrograde ejaculation was rare in patients treated with HoLEP and was common in M-TURP (Fig. 7E and F).

Discussion

Lower urinary tract symptoms (LUTS) are significantly associated with bladder outlet obstruction.89% of patients with bladder outlet obstruction was due to benign prostatic obstruction.[ Monopolar TURP is an effective method for the treatment of BPH and has been regarded as gold standard for decades. However, M-TURP is always accompanied by various complications, such as transurethral resection syndrome, bleeding, clot retention and retrograde ejaculation. To improve the efficiency and reduce these complications, various transurethral procedures have been developed, such as transurethral electrovaporization of prostate (TUVP), bipolar TURP and various lasers. Each procedure has its own advantage and disadvantage. Nørby et al[ also investigated the cost-effectiveness of different treatments for benign prostatic hyperplasia through a short-term follow-up. In this study, we made a network meta-analysis and compare the efficacy and safety of different transurethral procedures for the treatment of BPH. Nd:YAG laser, KTP/Nd:YAG laser and interstitial laser coagulation were popular procedures in the last century and rarely used today.[ No matter in direct analysis or in our network meta-analysis, they have no advantages compared with other techniques.[ We also found that M-TURP, TUVP,[ and TURis were ordinary in effectiveness and were associated with higher complications. Based on the results of our study, thulium laser, holmium laser, diode laser, greenlight laser, and plasmakinetic system are advantageous. Compared to other procedures, 3 types of lasers exhibited ideal results in terms of Qmax, PVR, IPSS, and QoL:HoLEP was the best one for PVR improvement. TmLRP had the best efficacy in improving QoL score. Diode laser vaporization of prostate was superior in improving IPSS and Qmax. For the perioperation-related outcomes, PKRP needed the fewest operation time while holmium laser and thulium laser took the longest time. Diode laser through vaporization required the shortest catheterization time. HoLEP required the shortest hospitalization time. In general, laser operation procedures required relatively longer operation time compared with TURP.[ In fact, catheterization and hospitalization time are more important for patients. So thulium laser, holmium laser, and diode laser showed had better surgical efficacy. Effectiveness and safety are 2 equally important factors to evaluate the surgical techniques. For safety, thulium laser, diode laser and holmium laser have relatively higher performance. Thulium laser was first used in 2004.[ The center wavelength of thulium laser is tunable between 1.75 and 2.22 μm, which exactly matches the 1.92 μm water absorption peak in tissues. This character implies higher energy absorption at the surface of tissue. Due to the advantage, thulium laser is performed excellently in vaporization and hemostasia. Studies also showed that histological analysis following laser transurethral resection of the prostate will be helpful for the prostate cancer screening.[ In this meta-analysis, TmLRP led the lowest postoperative hemoglobin decrease and had the least rates of occurrence of hematuria. More rapid vaporization makes it similar to resection, vaporization or enucleation actually. The second advantage of thulium laser is the thin penetration depth, which is from 0.5 to 2 mm.[ The thinner coagulation depth means minimal thermal injury to surrounding tissues. TmLEP had the least rates of erectile dysfunction, which may be related to the better protection for nervi erigentes. Diode laser also has high absorption in water and hemoglobin,[ and the hemostasia was proved by the minimum occurrence of blood transfusion in this meta-analysis. Moreover, Razzaghi et al[ showed the coagulation rim of diode laser is from 0.2 to 1 mm. Due to the smaller thickness of coagulative range and less thermal injury, the complications, such as urethral stricture and bladder neck contracture, relatively rare in the patients who underwent diode laser vaporization. For holmium laser, the enucleation[ was more widely used than resection.[ A large number of studies[ proved that HoLEP was a safe choice for the treatment of BPH and HoLEP led to the lowest incidence of recatheterization, urinary retention, urinary tract infection, stress urinary incontinence and retrograde ejaculation in our research. But However, it is also remarkable that HoLEP has potential damage of prostate capsule because of its pulse work mode and requirement of tissue morcellatio.[ In general, thulium laser, diode laser, and holmium laser were equally with high efficacy and safety.[ Greenlight laser is one of the most common surgical energy platforms for the treatment of BPH. The wavelength of greenlight is 532 nm, which can fully absorbed by oxyhemoglobin, but hardly absorbed by water.[ This character means better for hemostasia but deeper thermal injury to surrounding tissues. That was the reason that PVP was associated with the most rare incidences of clot retention, but relatively worse in erectile dysfunction and bladder neck contracture in our meta-analysis. Al-Ansari et al[ and Capitan et al[ proved that PVP and TURP have the same complication rate. The plasmakinetic surgical also have various advantages: ability to work in saline, more efficacious in resection, and a smooth wound surface. By virtue of the superiorities, transurethral plasmakinetic prostatectomy was proved to significantly reduce TURS and dysuria in our meta-analysis. But many studies showed that plasmakinetic surgical was inferior to thulium laser, holmium laser and diode laser in hemorrhage, recovery time, catheterization and hospitalization time.[ So, further research about plasmakinetic technique is needed. There were also some limitations for this meta-analysis. Due to the update of equipment, one kind of laser usually corresponds different sizes of power (about enrolled RCTs, thulium laser 50, 70, 90, 100, 120 W; holmium laser 80, 90, 100 W; PVP 80, 120, 180 W). The volume of prostate in every trial was not exactly equal to each other. In conclusion, this study showed comprehensive comparison of transurethral surgeries. For IPSS and Qmax, diode laser vaporization of prostate was the first choice. For PVR, HoLEP was the best choice. For QoL, TmLRP was the best technique. Compared with other transurethral procedures, thulium, holmium and diode lasers were associated with better efficacy outcomes and fewer complications. It will be helpful for the doctors to make choice from different procedures for the patients with BPH.

Author contributions

Conceptualization: Feng Sun. Data curation: Qinglu Shi. Formal analysis: Yuzhang Zhai. Investigation: Feng Sun, Xincheng Sun. Methodology: Feng Sun. Project administration: Feng Sun. Resources: Feng Sun. Software: Feng Sun. Supervision: Feng Sun. Validation: Feng Sun. Visualization: Feng Sun. Writing – original draft: Feng Sun. Writing – review & editing: Feng Sun.
Table 1 (Continued)

The basic characteristics of included randomly controlled trials.

  9 in total

1.  Analgesic Effects of Dexmedetomidine Combined with Spinal and Epidural Anesthesia Nursing on Prostate Hyperplasia Patients after Transurethral Resection of Prostate by Intelligent Algorithm-Based Magnetic Resonance Imaging.

Authors:  Xiaoyan Zhang; Manyun Bo; Rong Zeng; Liping Zou; Yanfang He
Journal:  Comput Math Methods Med       Date:  2022-05-21       Impact factor: 2.809

2.  Effect of hospital, community and home care model on nursing and quality of life of patients after transurethral resection of benign prostatic hyperplasia.

Authors:  Cuiping Niu; Xiaoling Huang; Lin Wang; Feng Liu
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

3.  Cost-Effectiveness and Budget Impact of Emerging Minimally Invasive Surgical Treatments for Benign Prostatic Hyperplasia.

Authors:  Bilal Chughtai; Sirikan Rojanasarot; Kurt Neeser; Dmitry Gultyaev; Stacey L Amorosi; Neal D Shore
Journal:  J Health Econ Outcomes Res       Date:  2021-05-06

4.  Risk Factors for Early Urethral Stricture After Mono-Polar Transurethral Prostate Resection: A Single-Center Experience.

Authors:  Ahmet Gür; Gökhan Sönmez; Türev Demirtaş; Şevket T Tombul; Kemal Halitgil; Abdullah Demirtaş
Journal:  Cureus       Date:  2021-11-17

5.  The efficacy of a suppository based on Phenolmicin P3 and Bosexil (Mictalase®) in control of irritative symptoms in patients undergoing thulium laser enucleation of prostate: a single-center, randomized, controlled, open label, phase III study.

Authors:  Riccardo Bertolo; Chiara Cipriani; Matteo Vittori; Marco Carilli; Francesco Maiorino; Valerio Iacovelli; Carlo Ganini; Michele Antonucci; Marta Signoretti; Filomena Petta; Massimo Panei; Pierluigi Bove
Journal:  BMC Urol       Date:  2022-02-12       Impact factor: 2.264

6.  Application of Prostate Resection Endoscopy for Treating Acute Obstruction Associated with Rectal Cancer.

Authors:  Peng Yan; Yujie Qin; Zhenming Zhang; Wenshan Xu; Jun Qian; Song Tu; Jiaxi Yao
Journal:  J Cancer       Date:  2022-03-14       Impact factor: 4.207

7.  The Efficacy and Safety of HoLEP for Benign Prostatic Hyperplasia With Large Volume: A Systematic Review and Meta-Analysis.

Authors:  Fengze Sun; Huibao Yao; Xingjun Bao; Xiaofeng Wang; Di Wang; Dongxu Zhang; Zhongbao Zhou; Jitao Wu
Journal:  Am J Mens Health       Date:  2022 Jul-Aug

8.  Retrograde Ejaculation-a Commonly Unspoken Aspect of Prostatectomy for Benign Prostatic Hypertrophy.

Authors:  Gideon Koren; Dan Koren
Journal:  Am J Mens Health       Date:  2020 Mar-Apr

9.  Endoscopic enucleation vs endoscopic vaporization procedures for benign prostatic hyperplasia: how should we choose: A protocol for systematic review and meta-analysis.

Authors:  Xinbao Yin; Jun Chen; Hui Sun; Ming Liu; Zehua Wang; Benkang Shi; Xueping Zheng
Journal:  Medicine (Baltimore)       Date:  2020-11-13       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.